Galapagos NV - ADR Shares Close the Day 22.5% Higher - Daily Wrap
The company saw its shares close the day 22.5% higher than yesterday, with trading volume higher than its 30 day average.
Jan 28, 2022 by Kwhen Finance Editors
Galapagos NV - ADR (GLPG) shares closed today 22.5% higher than it did at the end of yesterday. The stock is currently up 18.4% year-to-date, down 40.1% over the past 12 months, and down 2.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 fell 0.5%.
Trading Activity
- Shares traded as high as $65.86 and as low as $52.34 this week.
- Shares closed 40.5% below its 52-week high and 40.7% above its 52-week low.
- Trading volume this week was 28.5% lower than the 10-day average and 39.2% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Galapagos NV - ADR | 22.5 | 18.4 | -40.1 | ||
| Dow Jones Industrial Average | 0.0 | -5.9 | 14.6 | -6.7 | 17.3 |
| S&P 500 Index | -0.5 | -9.2 | 16.7 | -8.7 | 20.6 |
| Technology Industry | 1.6 | 47.8 | -50.1 | -58.6 | 45.1 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -1152.8%
- The company's stock price performance over the past 12 months lags the peer average by -1082.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Galapagos NV - ADR | GLPG | 0 | 18.4 | -40.1 | ||
| Peer Avg | N/A | 27.7 | -1.8 | 4.1 | -7.6 | 54.3 |
| Johnson & Johnson | JNJ | 25.1 | -0.3 | 4.2 | -4.7 | 13.9 |
| Abbvie Inc | ABBV | 32.2 | 1.5 | 38.4 | -1.7 | 39.8 |
| Abbott Laboratories | ABT | 29.4 | -14.1 | 7.0 | -14.9 | 16.1 |
| Merck & Co Inc | MRK | 27.8 | 3.3 | 2.2 | -13.3 | 426.5 |
| Astrazeneca plc - ADR | AZN | 123.9 | 2.2 | 17.4 | ||
| Sanofi - ADR | SNY | 8.8 | 5.5 | 15.9 | ||
| Glaxosmithkline plc - ADR | GSK | 17.7 | 3.7 | 26.7 | -4.8 | 38.2 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.5 | 2.7 | -32.7 | -36.8 | 8.7 |
| Fortress Biotech Inc | FBIO | 0 | -22.0 | -38.3 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: